Looker Benjamin (CIK 0001859509)

Latest company ownership

ESPR - Esperion Therapeutics, Inc.

Role: General Counsel

Shares held

392,422

Last filed at

Oct 20, 2025

Confidence Score

22.0

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 17, 2025	Dec 18, 2025	Esperion Therapeutics, Inc.	General Counsel	Sell	26.3	-6,517	-1.66%	✗	$23.9K
Oct 17, 2025	Oct 20, 2025	Esperion Therapeutics, Inc.	General Counsel	Sell	45.0	-1,248	-0.32%	✗	$3.3K
Sep 17, 2025	Sep 18, 2025	Esperion Therapeutics, Inc.	General Counsel	Sell	26.3	-6,267	-1.57%	✗	$17.6K
Jul 17, 2025	Jul 18, 2025	Esperion Therapeutics, Inc.	General Counsel	Sell	45.0	-1,304	-0.32%	✗	$1.5K
Jun 17, 2025	Jun 18, 2025	Esperion Therapeutics, Inc.	General Counsel	Sell	27.5	-6,422	-1.58%	✗	$7.4K
Apr 19, 2023	Apr 20, 2023	Esperion Therapeutics, Inc.	General Counsel	Sell	27.5	-1,290	-1.52%	✗	$1.6K
Jan 18, 2023	Jan 19, 2023	Esperion Therapeutics, Inc.	General Counsel	Sell	26.3	-6,347	-8.96%	✗	$44.4K